Sol Gel Technologies Ltd
NASDAQ:SLGL

Watchlist Manager
Sol Gel Technologies Ltd Logo
Sol Gel Technologies Ltd
NASDAQ:SLGL
Watchlist
Price: 0.534 USD 12.4% Market Closed
Market Cap: 14.9m USD
Have any thoughts about
Sol Gel Technologies Ltd?
Write Note

Relative Value

The Relative Value of one SLGL stock under the Base Case scenario is 0.721 USD. Compared to the current market price of 0.534 USD, Sol Gel Technologies Ltd is Undervalued by 26%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SLGL Relative Value
Base Case
0.721 USD
Undervaluation 26%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
98
vs Industry
12
Median 3Y
13
Median 5Y
15
Industry
2.5
Forward
1.7
vs History
vs Industry
Median 3Y
-1.3
Median 5Y
-4.6
Industry
21.9
Forward
-0.9
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-9.3
Industry
16.5
vs History
vs Industry
Median 3Y
-8.3
Median 5Y
-9.2
Industry
23.6
vs History
96
vs Industry
70
Median 3Y
2.1
Median 5Y
2.7
Industry
2.1
vs History
vs Industry
86
Median 3Y
3.3
Median 5Y
8
Industry
2.6
Forward
-1.5
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
5.2
vs History
19
vs Industry
52
Median 3Y
0.4
Median 5Y
-2.9
Industry
13.3
vs History
19
vs Industry
49
Median 3Y
0.4
Median 5Y
-2.8
Industry
16.6
Forward
0.8
vs History
1
vs Industry
51
Median 3Y
-5.8
Median 5Y
-6.6
Industry
15.6
vs History
1
vs Industry
38
Median 3Y
-5.7
Median 5Y
-6.4
Industry
19.1
vs History
vs Industry
76
Median 3Y
5.5
Median 5Y
6.9
Industry
1.9

Multiples Across Competitors

SLGL Competitors Multiples
Sol Gel Technologies Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Sol Gel Technologies Ltd
NASDAQ:SLGL
14.9m USD 1.3 -1.6 1.2 1.2
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
710.5B USD 17.4 84.9 45.7 51
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.3 27.8
US
Johnson & Johnson
NYSE:JNJ
373.5B USD 4.3 25.4 12.3 16
US
Merck & Co Inc
NYSE:MRK
251.1B USD 4 20.7 10.5 12.5
CH
Roche Holding AG
SIX:ROG
202.7B CHF 3.5 17.6 9.9 11.8
CH
Novartis AG
SIX:NOVN
183.3B CHF 4.1 11.6 10.1 14
UK
AstraZeneca PLC
LSE:AZN
162.4B GBP 4.1 31.6 169.4 253.9
IE
Endo International PLC
LSE:0Y5F
146B USD 63 -49.9 234.4 587.7
P/E Multiple
Earnings Growth
IL
Sol Gel Technologies Ltd
NASDAQ:SLGL
Average P/E: 32.4
Negative Multiple: -1.6
N/A
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
84.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25.4
-22%
US
Merck & Co Inc
NYSE:MRK
20.7
7 321%
CH
Roche Holding AG
SIX:ROG
17.6
32%
CH
Novartis AG
SIX:NOVN
11.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.6
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -49.9 N/A

See Also

Discover More
Back to Top